Mus vs Pakistan: The number of people with susceptibility test result for rifampicin
Mus
83
in 2021
Pakistan
125,823
in 2021
Mus rank
1st
Pakistan rank
4th
The number of people with susceptibility test result for rifampicin over time
- Mus
- Pakistan
How they compare
Pakistan currently reports 125,823 against 83 in Mus, a difference of 125,740.
That makes Pakistan's figure about 1,515.9 times Mus's.
Across all 5 years both countries report, Pakistan has been ahead every year.
Mus ranks 1st and Pakistan ranks 4th of 2 regions.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 111 | 55,256 | 55,145 | Pakistan |
| 2020s | 83 | 99,270 | 99,188 | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mus or Pakistan?
- Pakistan, at 125,823 against 83 in Mus as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mus and Pakistan?
- 125,740, with Pakistan ahead.
- How many years of comparable data are there for Mus and Pakistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Mus and Pakistan rank globally for the number of people with susceptibility test result for rifampicin?
- Mus ranks 1st and Pakistan ranks 4th of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.